MedPath
FDA Approval

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 17, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral

Product Details

NDC Product Code
64380-116
Application Number
ANDA215469
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 17, 2024
Code: 0YPR65R21JClass: ACTIBQuantity: 17.5 g in 177 mL
Code: 1K573LC5TVClass: ACTIBQuantity: 3.13 g in 177 mL
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
MALIC ACIDInactive
Code: 817L1N4CKPClass: IACT
Code: DE08037SABClass: ACTIBQuantity: 1.6 g in 177 mL
© Copyright 2025. All Rights Reserved by MedPath